Cambios en la epidemiología y en la práctica clínica de la alergia mediada por IgE en pediatría
- Mercedes Escarrer-Jaume
- Juan Carlos Juliá-Benito
- Sergio Quevedo-Teruel
- Ana Prieto del Prado
- Mónica Sandoval-Ruballos
- Fabriella Quesada-Sequeira
- Montserrat Álvaro-Lozano
ISSN: 1695-4033, 1696-4608
Year of publication: 2021
Volume: 95
Issue: 1
Pages: 56-56
Type: Article
More publications in: Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )
Abstract
In the last decades, allergic diseases have increased exponentially and although pediatric asthma prevalence is stabilizing, in Spain is estimated around 10%. Not the same with food allergy and anaphylaxis which are clearly increasing, becoming a public health problem of the first magnitude. Considering epidemiological trends, the European Academy of Allergy and Clinical Immunology (EAACI) estimates that in less than 15 years more than half of European population will suffer from some type of allergy. The advances in diagnostic methods in food allergy, especially component resolved diagnosis, allow us to know the patient's sensitization profile and explain the possible cross reactivity, anticipate potential risk of food transgressions, and prescribe the correct avoidance diet in each patient. Thus, the development of molecular biology and nanotechnology have led to the appearance of new technologies (microarrays) which facilitate the study, specially of the polysensitized patients, allowing allergen immunotherapy (AIT) to be more personalized. The latest advances in the use of biologics are having an impact, not only in disease evolution, but also in patients quality of life.